Perspective Therapeutics announced data presentations at ASCO 2025 for its cancer treatment programs [212Pb]VMT-α-NET and [212Pb]VMT01. Perspective Therapeutics, Inc. announced that it will present ...

Jasper Therapeutics, Inc., a biotechnology company focused on developing briquilimab, an antibody therapy for mast cell-driven diseases, announced several presentations related to briquilimab at the ...